The Ohio State University Wexner Medical Center

Research CenterTreats Aortic, Mitral, and Pulmonary valves

AI Description

The Ohio State University Wexner Medical Center’s Structural Heart Disease Program evaluates and treats aortic and mitral valve disease with cardiologists, interventional cardiologists, cardiac surgeons and other specialists. Care includes valve repair and replacement, balloon valvuloplasty, minimally invasive procedures and transcatheter aortic valve replacement (TAVR) for aortic stenosis or regurgitation.

This description was generated by AI based on public sources. Data Sources and Methodology · Report inaccurate information

Location and Contact

410 West 10th Avenue
Columbus, OH 43210

Clinical Trials

Active, not recruiting

SURTAVI

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).

Public sites
56
Start date
Apr 1, 2012
Recruiting

CLASP II TR

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Public sites
70
Start date
Dec 11, 2019
Active, not recruiting

PORTICO-IDE

Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial

Public sites
59
Start date
May 1, 2014
Recruiting

APOLLO

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Public sites
71
Start date
Oct 23, 2017
Recruiting

MVSS

Mitral Valve Screening Survey

Public sites
10
Start date
Aug 6, 2021

Nearby Centers